PRESS RELEASE published on 10/23/2023 at 22:22, 1 year ago EQS-Adhoc: Nemetschek SE increases revenue guidance for the financial year 2023
PRESS RELEASE published on 09/05/2023 at 09:03, 1 year 2 months ago Nemetschek Group Forms New Executive Leadership Team for its Next Phase of Growth
PRESS RELEASE published on 07/31/2023 at 07:00, 1 year 3 months ago Nemetschek SE: First Half of 2023 on Plan – Continued Strong Growth in Subscription and SaaS in Q2 2023
PRESS RELEASE published on 04/27/2023 at 07:00, 1 year 6 months ago Nemetschek SE: Successful Start to the Year in Q1 2023 with Continued Strong Growth in Subscriptions and SaaS
PRESS RELEASE published on 03/23/2023 at 07:00, 1 year 7 months ago Nemetschek SE lays decisive foundations for future dynamic growth after successful 2022 financial year
PRESS RELEASE published on 03/17/2023 at 11:50, 1 year 8 months ago Nemetschek Group proposes dividend increase by 15.4% to EUR 0.45 per share
PRESS RELEASE published on 02/14/2023 at 07:00, 1 year 9 months ago Nemetschek Group Achieves Its Revenue and Profitability Targets in the Fiscal Year 2022
Published on 11/21/2024 at 13:00, 28 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 28 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 28 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 28 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 28 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 52 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 12 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 30 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 8 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 43 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 43 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
